Circulating Metabolic Intermediates as Fuels and Signals
Circulating Metabolic Intermediates as Fuels and Signals
批准号:
10753880
负责人:
TERRY L. SHEPPARD
金额:
$1.89万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-07-01 至 2024-06-30
关键词:
AddressAmino AcidsBenignBiologyCause of DeathCollaborationsConsensusDataDevelopmentDiabetes MellitusDisciplineDiseaseEducational workshopFatty acid glycerol estersFutureGlucoseGoalsHealthHeart DiseasesImmuneInterventionKnowledgeLearningMalignant NeoplasmsMentorsMetabolicMetabolic DiseasesMetabolic syndromeMetabolismMethodologyMuscleObesityOutcomeRegulationResearchResearch PersonnelRoleScienceScientistSignal TransductionStrokeSuccinatesUtahVisionclinical practicedesigndisabilityhuman diseaseimprovedmicrobiotamultidisciplinarynew technologynonalcoholic steatohepatitisnovel therapeutic interventionpostersprospectivesymposiumsynergismtranslational potentialwasting
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Support is requested for a Keystone Symposia conference entitled Circulating Metabolic Intermediates as Fuels
and Signals, organized by Drs. Sven Enerbäck, Joshua Rabinowitz and Sarah-Maria Fendt. The conference will
be held in Snowbird, Utah from October 8-11, 2023.
Metabolic diseases such as stroke, heart disease, diabetes, cancer, obesity, and NASH remain major causes of
death and disability. One reason for this is due to the incomplete understanding of metabolism and its regulation.
New data indicate that metabolites normally viewed as wastes or benign intermediates are actually very
important fuels and signals. For example, lactate has emerged as an important energy substrate and succinate
as a driver of muscle remodeling, reflecting the many underexplored roles of circulating metabolic intermediates.
The importance of such intermediates, as opposed to classical “fuels” like glucose, amino acids and fat, opens
a new perspective on how metabolism is controlled. Thus, this field is primed for further breakthroughs, both in
understanding of new biology and in offering new targets for intervention. This Keystone Symposia conference
will bring together the leading experts in the field to review the latest research and discuss challenges the field
is facing. Finally, this conference is being held jointly with the Keystone Symposia conference on Mechanisms
of Microbiota-Immune Interactions-Towards the Next Decade. It is anticipated that this paring will lead to new
scientific collaborations and the implementation of new technological approaches directed at understanding the
underlying mechanisms of microbiota-immune and -metabolic interactions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pulmonary Hypertension: State of the Art and Therapeutic Opportunities
-
批准号:10682118
-
项目类别:
-
资助金额:$1.53万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Infections in Pregnancy: PathogenicMechanisms, Experimental Advances and Clinical Strategies
-
批准号:10540260
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Mechanisms of Microbiota-Immune Interactions-Towards the Next Decade
-
批准号:10753451
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Vaccinology During and After COVID-19
-
批准号:10753782
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Transposable Elements at the Crossroads of Evolution, Health and Disease
-
批准号:10750852
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment
-
批准号:10749522
-
项目类别:
-
资助金额:$2.13万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
-
批准号:10683443
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Metastasis
-
批准号:10681132
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Inflammation in the Lung: Friend or Foe in Viral Infections?
-
批准号:10681956
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
HIV Vaccines, Immunoprophylaxis and Drugs
-
批准号:10699245
-
项目类别:
-
资助金额:$2.13万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
B Cells and Tertiary Lymphoid Structures: Emerging Targets in Cancer Therapeutics
-
批准号:10754008
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Myeloid Cell Diversity: From Fundamental Biology to Disease States
-
批准号:10753412
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
RNA Modifications in Health and Disease
-
批准号:10754076
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Emerging Cellular Therapies at the Forefront of Cancer Immunotherapy
-
批准号:10540496
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
From First Breath: Lung Development, Infection, Repair and Aging
-
批准号:10678811
-
项目类别:
-
资助金额:$1.65万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Precision Genome Engineering
-
批准号:10608865
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
T and B Cell Collaboration in Germinal Centers and Beyond
-
批准号:10753621
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Type 2 Diabetes: Understanding its Early Drivers and the Road to Therapeutics
-
批准号:10682747
-
项目类别:
-
资助金额:$1.32万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Metabolic and Molecular Mechanisms of NAFLD/NASH
-
批准号:10682156
-
项目类别:
-
资助金额:$1.92万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Heart Development and Disease: From Genes to Cures
-
批准号:10608624
-
项目类别:
-
资助金额:$1.62万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
海外基金